Singapore markets close in 3 hours 40 minutes

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.1200+0.0200 (+0.65%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
3,595
2,296
4,507
0
0
Operating expenses
Research development
45,941
56,414
95,140
87,716
78,803
Selling general and administrative
26,904
28,816
34,404
27,536
15,119
Total operating expenses
72,845
85,230
129,544
115,252
93,922
Operating income or loss
-69,250
-82,934
-125,037
-115,252
-93,922
Total other income/expenses net
1,550
4,544
-
-
-
Income before tax
-67,621
-77,802
-123,008
-115,252
-93,922
Income from continuing operations
-67,621
-77,802
-123,008
-115,252
-93,922
Net income
-67,621
-77,802
-123,008
-115,252
-93,922
Net income available to common shareholders
-67,621
-77,802
-123,008
-115,561
-93,922
Basic EPS
-
-2.56
-4.49
-4.22
-3.44
Diluted EPS
-
-2.56
-4.49
-4.22
-3.44
Basic average shares
-
30,403
27,380
27,304
27,304
Diluted average shares
-
30,403
27,380
27,304
27,304
EBITDA
-
-80,637
-122,337
-113,724
-92,177